A bottle of metformin 500 mg from Sun Pharma and a bottle of metformin 500 mg from a Tier-3 Indian […]

Every year, drug companies leave hundreds of millions of dollars on the table. Not because their molecules fail, not because

When Pfizer paid $11.6 billion for Array BioPharma in 2019, analysts praised the deal’s logic. Two years later, generic manufacturers

Ask anyone in pharma how long a drug patent lasts and they’ll say 20 years. The number is technically correct

When a buyer writes a $74 billion check for a drugmaker, they are not paying for the molecule. They are

Most pharmaceutical IP work gets framed as a pre-approval problem. File the composition patent during discovery, secure the use claims

The most expensive number in pharmaceutical finance is the one nobody on the executive team wants to commit to: how

Every time a pharmaceutical company changes something about an approved drug, it opens two doors simultaneously. The first leads to

The pharmaceutical industry has a math problem. A blockbuster drug throws off cash at a rate that makes any other